Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.2300 (-4.74%) ($5.0700 - $5.5000) on Wed. Sep. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.55% (three month average) | RSI | 41 | Latest Price | $5.2300(-4.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(21%) GLD(6%) ARKG(5%) IPO(1%) IBUY(0%) | Factors Impacting CAPR price | CAPR will decline at least -4.275% in a week (0% probabilities). URA(-47%) XLB(-35%) PAVE(-31%) XOP(-27%) OIH(-27%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.275% (StdDev 8.55%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-14.23(-372.08%) | Inflection Point | Yes | Resistance Level | $5.9 | 5 Day Moving Average | $5.52(-5.25%) | 10 Day Moving Average | $5.54(-5.6%) | 20 Day Moving Average | $5.9(-11.36%) | To recent high | -46.7% | To recent low | 4.4% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |